| 528.81 4.82 (0.92%) | 01-26 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 667.29 | 1-year : | 705.33 |
| Resists | First : | 571.31 | Second : | 603.88 |
| Pivot price | 554.01 |
|||
| Supports | First : | 518.64 | Second : | 431.5 |
| MAs | MA(5) : | 525.94 |
MA(20) : | 558.22 |
| MA(100) : | 518.78 |
MA(250) : | 520.85 |
|
| MACD | MACD : | -10.5 |
Signal : | -5.1 |
| %K %D | K(14,3) : | 8.8 |
D(3) : | 7.1 |
| RSI | RSI(14): 35.5 |
|||
| 52-week | High : | 609.08 | Low : | 425 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ISRG ] has closed above bottom band by 25.7%. Bollinger Bands are 72.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 534.43 - 538.2 | 538.2 - 541.13 |
| Low: | 511.65 - 515.62 | 515.62 - 518.7 |
| Close: | 523.61 - 529.77 | 529.77 - 534.56 |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Mon, 26 Jan 2026
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know - Yahoo Finance
Mon, 26 Jan 2026
Vanguard Personalized Indexing Management LLC Sells 3,766 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Mon, 26 Jan 2026
Lbp Am Sa Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG - MarketBeat
Sun, 25 Jan 2026
Whittier Trust Co. Buys 7,128 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Sun, 25 Jan 2026
CIBC Asset Management Inc Grows Stake in Intuitive Surgical, Inc. $ISRG - MarketBeat
Sat, 24 Jan 2026
Rockport Wealth LLC Grows Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 355 (M) |
| Shares Float | 352 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 89.1 (%) |
| Shares Short | 7,440 (K) |
| Shares Short P.Month | 7,170 (K) |
| EPS | 7.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 47.7 |
| Profit Margin | 28.5 % |
| Operating Margin | 30.3 % |
| Return on Assets (ttm) | 9.5 % |
| Return on Equity (ttm) | 16.8 % |
| Qtrly Rev. Growth | 22.8 % |
| Gross Profit (p.s.) | 17.99 |
| Sales Per Share | 27.1 |
| EBITDA (p.s.) | 9.61 |
| Qtrly Earnings Growth | 25 % |
| Operating Cash Flow | 2,960 (M) |
| Levered Free Cash Flow | 1,970 (M) |
| PE Ratio | 70.13 |
| PEG Ratio | 0 |
| Price to Book value | 11.08 |
| Price to Sales | 19.5 |
| Price to Cash Flow | 63.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |